These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27276675)
1. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection. Li Z; Yamada S; Wu Y; Wang KY; Liu YP; Uramoto H; Kohno K; Sasaguri Y Oncotarget; 2016 Aug; 7(34):54463-54473. PubMed ID: 27276675 [TBL] [Abstract][Full Text] [Related]
2. Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival. Li Z; Yamada S; Inenaga S; Imamura T; Wu Y; Wang KY; Shimajiri S; Nakano R; Izumi H; Kohno K; Sasaguri Y Br J Cancer; 2011 Jun; 104(12):1882-9. PubMed ID: 21587259 [TBL] [Abstract][Full Text] [Related]
3. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma. Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641 [TBL] [Abstract][Full Text] [Related]
6. GalNAc-T3 and MUC1, a combined predictor of prognosis and recurrence in solitary pulmonary adenocarcinoma initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm). Xie Q; Li F; Zhao S; Guo T; Li Z; Fang L; Wang S; Liu W; Gu C Hum Cell; 2020 Oct; 33(4):1252-1263. PubMed ID: 32776306 [TBL] [Abstract][Full Text] [Related]
7. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Shibao K; Izumi H; Nakayama Y; Ohta R; Nagata N; Nomoto M; Matsuo K; Yamada Y; Kitazato K; Itoh H; Kohno K Cancer; 2002 Apr; 94(7):1939-46. PubMed ID: 11932895 [TBL] [Abstract][Full Text] [Related]
8. Expression of Polypeptide Murakami M; Kagami S; Nguyen TT; Koi C; Kurita T; Hachisuga T Anticancer Res; 2017 Jul; 37(7):3911-3915. PubMed ID: 28668894 [TBL] [Abstract][Full Text] [Related]
9. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma. Guo T; Zhao S; Li Z; Li F; Li J; Gu C Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer. He H; Shen Z; Zhang H; Wang X; Tang Z; Xu J; Sun Y Br J Cancer; 2014 Apr; 110(8):2021-9. PubMed ID: 24619076 [TBL] [Abstract][Full Text] [Related]
14. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma. Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754 [TBL] [Abstract][Full Text] [Related]
15. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma. Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085 [TBL] [Abstract][Full Text] [Related]
16. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma. Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170 [TBL] [Abstract][Full Text] [Related]
17. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Gu C; Oyama T; Osaki T; Li J; Takenoyama M; Izumi H; Sugio K; Kohno K; Yasumoto K Br J Cancer; 2004 Jan; 90(2):436-42. PubMed ID: 14735190 [TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma. Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911 [TBL] [Abstract][Full Text] [Related]
20. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection. Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]